CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Frequently asked questions
What sector does CBLL (CBLL) operate in?
CBLL belongs to the Healthcare sector and operates in the Medical Devices industry.
What is CBLL (CBLL) current stock price?
As of the latest data, CBLL stock price is $24.51, with a previous close of $24.40. CBLL gained $0.11 in the last trading session, representing a 0.45% increase.
What is CBLL (CBLL) current market capitalization?
CBLL market cap is approximately 929.98 million.
What is CBLL (CBLL) Earnings Per Share (EPS)?
The trailing EPS is -$1.66, and the forward EPS is -$1.10.
What is CBLL (CBLL) EBITDA?
CBLL EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -19.98 million.
Does CBLL (CBLL) pay dividends?
No. CBLL does not pay a dividend.
How did CBLL (CBLL) perform in its most recent earnings report?
In the last report (June 30, 2026), CBLL posted an EPS surprise of 15.56% and a revenue surprise of 2.99%.
What is CBLL (CBLL) beta (volatility) score?
CBLL has a beta of 0.157, indicating lower volatility than the overall market.
